BizCommunity - 22 Nov 2022
The Global Antibiotic Research and Development Partnership (GARDP), together with the South African Medical Research Council (SAMRC) has launched a study in South Africa that will give valuable insights into the increasing rate of antibiotic-resistant infections in hospitals.
The observational study will collect and analyse data in 150 patients being treated for infections caused by carbapenem-resistant organisms across five hospitals in South Africa.
The study gets underway this month at Livingstone Hospital in Gqeberha, followed by Groote Schuur Hospital in Cape Town, Chris Hani Baragwanath Academic Hospital in Soweto, King Edward VIII Hospital in Durban and Tygerberg Hospital in Cape Town.
“We are seeing rising rates of resistance to carbapenems – the class of antibiotics most commonly used to treat hospital-acquired multidrug-resistant bacterial infections,” said François Franceschi, GARDP’s project lead for serious bacterial infections.
Read more: